ロード中...
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...
保存先:
| 出版年: | Metab Brain Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/ https://ncbi.nlm.nih.gov/pubmed/27525431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|